New Isotopes for the Treatment of Pancreatic Cancer in Collaboration With CERN: A Mini Review
Authors:
Open Access
- 2 August 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8, 674656
Abstract
The use of radioactivity in medicine has been developed over a century. The discovery of radioisotopes and their interactions with living cells and tissue has led to the emergence of new diagnostic and therapeutic modalities. The CERN-MEDICIS infrastructure, recently inaugurated at the European Center for Nuclear Research (CERN), provides a wide range of radioisotopes of interest for diagnosis and treatment in oncology. Our objective is to draw attention to the progress made in nuclear medicine in collaboration with CERN and potential future applications, in particular for the treatment of aggressive tumors such as pancreatic adenocarcinoma, through an extensive review of literature. Fifty seven out of two hundred and ten articles, published between 1997 and 2020, were selected based on relevancy. Meetings were held with a multi-disciplinary team, including specialists in physics, biological engineering, chemistry, oncology and surgery, all actively involved in the CERN-MEDICIS project. In summary, new diagnostic, and therapeutic modalities are emerging for the treatment of pancreatic adenocarcinoma. Targeted radiotherapy or brachytherapy could be combined with existing therapies to improve the quality of life and survival of these patients. Many studies are still in the pre-clinical stage but open new paths for patients with poor prognosis.Keywords
This publication has 61 references indexed in Scilit:
- Pilot trial of endoscopic ultrasound-guided interstitial chemoradiation of UICC-T4 pancreatic cancerEndoscopic Ultrasound, 2012
- The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapyNuclear Medicine and Biology, 2011
- Clinical Investigations Perioperative high dose rate (HDR) brachytherapy in unresectable locally advanced pancreatic tumorsJournal of Contemporary Brachytherapy, 2011
- Clinical Investigations Adjuvant high dose rate brachytherapy for soft tissue sarcomas: initial experience reportJournal of Contemporary Brachytherapy, 2011
- Neoadjuvant peptide receptor radionuclide therapy for aninoperable neuroendocrine pancreatic tumorWorld Journal of Gastroenterology, 2009
- Improving Gemcitabine-Mediated Radiosensitization Using Molecularly Targeted Therapy: A ReviewClinical Cancer Research, 2008
- A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic CarcinomaCancer Research, 2008
- Somatostatin-receptor-targeted α-emitting 213Bi is therapeutically more effective than β−-emitting 177Lu in human pancreatic adenocarcinoma cellsNuclear Medicine and Biology, 2007
- Placement of 125I implants with the da Vinci robotic system after video-assisted thoracoscopic wedge resection: A feasibility studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999